← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
POWERS JOHNNY D
Director
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001134545
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 3
- Purchases · 24M
- 6
- Average purchase
- $27.7K
- Median purchase
- $23.0K
- Gross purchase value
- $166.0K
Companies: Zomedica Corp.
6 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-05-21 | Zomedica Corp. | ZOMDF | Director | $20.0K | Open filing |
| 2026-05-14 | Zomedica Corp. | ZOMDF | Director | $33.0K | Open filing |
| 2026-05-11 | Zomedica Corp. | ZOMDF | Director | $55.0K | Open filing |
| 2025-05-20 | Zomedica Corp. | ZOMDF | Director | $25.0K | Open filing |
| 2025-03-18 | Zomedica Corp. | ZOM | Director | $21.0K | Open filing |
| 2024-11-12 | Zomedica Corp. | ZOM | Director | $12.0K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
No completed point-in-time price outcome is available yet.
Research patterns
- First purchase in 12M
- 0/5
- Large purchase ≥ $100k
- 0/6
- Cluster buying · 15D
- 6/6
- Buying the dip
- 0/—
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.